OFFICIAL TRANSCRIPT
PROCEEDINGS BEFORE

THE SUPREME COURT
OF THE
UNITED STATES
CAPTION:

DONNA E. SHALALA, SECRETARY OF HEALTH &
HUMAN SERVICES, Petitioner v. MARGARET
WHITECOTTON, ET AL.

CASE NO:

No. 94-372

PLACE:

Washington, D.C.

DATE:

Tuesday, February 28, 1995

PAGES:

1-50

ALDERSON REPORTING COMPANY
1111 14TH STREET, N.W.
WASHINGTON, D.C. 20005-5650
202 289-2260

RhCris/ELt

SUPRhHt-: CQURT.U.S
MARSHAL'S Of* !Cf

*95 MAR-7 AIO SO

IN THE SUPREME COURT OF THE UNITED STATES

1

2

--------------- -X

3

DONNA E. SHALALA, SECRETARY

4

OF HEALTH & HUMAN SERVICES,

:

Petitioner

5
6

:

:

v.

:

7

MARGARET WHITECOTTON, ET AL.

8

--------------- -X

No. 94-372

:

Washington, D.C.

9

Tuesday, February 28, 1995

10

The above-entitled matter came on for oral

11
12

argument before the Supreme Court of the United States at

13

10:05 a.m.

14

APPEARANCES:

15

IRVING L. GORNSTEIN, ESQ., Assistant to the Solicitor

16

General, Department of Justice, Washington, D.C.; on

17

behalf of the Petitioner.

18

19

ROBERT THOMAS MOXLEY, ESQ., Cheyenne, Wyoming; on behalf
of the Respondents.

20
21
22

23
24
25
1

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

CONTENTS

1
2

ORAL ARGUMENT OF

3

IRVING L. GORNSTEIN, ESQ.

4

On behalf of the Petitioner

5

ORAL ARGUMENT OF

6

ROBERT THOMAS MOXLEY, ESQ.

7

On behalf of the Respondents

8

REBUTTAL ARGUMENT OF

9

IRVING L. GORNSTEIN, ESQ.

10

PAGE

On behalf of the Petitioner

11

12

13
14
15
16

17
18
19
20
21

22
23
24
25
2

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

3

26

40

PROCEEDINGS

1

(10:05 a.m.)

2

3

CHIEF JUSTICE REHNQUIST:

We'll hear argument

4

now in Number 94-372, Donna E. Shalala v. Margaret

5

Whitecotton.

6

Mr. Gornstein.

7

ORAL ARGUMENT OF IRVING L. GORNSTEIN

8

ON BEHALF OF THE PETITIONER

9
10
11

MR. GORNSTEIN:

Mr. Chief Justice, and may it

please the Court:
This case arises under the vaccine injury act

12

and involves an interpretation of two related provisions.

13

The first creates a presumption that a vaccine has caused

14

a child's condition when the first symptom or

15

manifestation of the onset of that condition occurs within

16

a specified period after the administration of a vaccine.

17

The second permits the Secretary to rebut the presumption

18

of causation by showing that the child's condition is due

19

to factors unrelated to the vaccine.

20

Our position is that the court of appeals erred

21

in its interpretation of each of these provisions.

22

start with the statutory presumption in section 300aa-ll,

23

which appears in page 2 of our brief.

24
25

Let me

The court of appeals interpreted the requirement
that the first symptom or manifestation of onset must
3
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

occur in the statutory period to mean that a presumption

2

of causation will arise whenever any manifestation of a

3

covered condition occurs after the administration of the

4

vaccine, even if that condition has already manifested

5

itself beforehand.

6

So under the court of appeals decision, if a

7

child has very clear manifestations of a serious brain

8

injury, and then has the vaccine, and then another

9

manifestation of the same condition, under the court of

10

appeals decision, there will be a presumption that the

11

vaccine caused the onset of the child's condition, and we

12

think that interpretation is incorrect for two reasons.

13

First, it is inconsistent with the use of the

14

statutory terms, first, and onset.

15

already manifested itself prior to the administration of a

16

vaccine, any manifestation of that same condition that

17

occurs after the administration of the vaccine cannot be

18

first, and it cannot be a manifestation of onset.

19

very first symptom or manifestation of onset necessarily

20

implied the absence of any preexisting symptom or

21

manifestation of that same condition.

22

When a condition has

The

The second reason that we think the court of

23

appeals erred in its interpretation is that its

24

interpretation fails to take into account the fact that

25

Congress specifically addressed cases where conditions had
4
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

already manifested themselves prior to the administration

2

of a vaccine through the significant aggravation

3

presumption.
Under section 300aa-ll, there is a separate

4
5

presumption of causation when the first symptom or

6

manifestation of a significant aggravation of a

7

preexisting condition occurs within the statutory period.

8

We think the clear import of that separate presumption is

9

that when a condition has already manifested itself prior

10

to the administration of the vaccine, a presumption that

11

the vaccine has something to do with the child's condition

12

can only arise when that preexisting condition has gotten

13

worse after the administration of the vaccine.

14

So under a simple and straightforward reading of

15

the statutory language, the simple existence of a symptom

16

or manifestation of a covered condition in the statutory

17

period is never enough by itself to trigger the

18

presumption that the vaccine has caused the child's

19

condition.

20

there's no preexisting symptom or manifestation of that

21

condition, or the child's condition has gotten markedly

22

worse afterwards.

23

In addition, it must either be the case that

By holding the court of appeals holding that the

24

existence of a symptom or manifestation of a condition in

25

the statutory period was sufficient by itself to trigger
5
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

the statutory presumption, we think the court of appeals

2

clearly erred.
QUESTION:

3

Mr. Gornstein, if we had only the

4

language that was in that table and not the statutory

5

language, wouldn't there be more of a case for the

6

opposite interpretation?

7

MR. GORNSTEIN:

Justice Ginsburg, I think even

8

if we were just looking at that table language, and that

9

appears, by the way, at page 4 of our brief, and says,

10

"Time period for first symptom or manifestation of onset

11

or of significant aggravation after vaccine

12

administration," there would be more of a case, but I

13

still think you would come to the same conclusion, because

14

the words "first" are still used in relation to the term

15

"onset" and I think when a condition has manifested itself

16

prior to vaccine administration, anything that comes after

17

that cannot be the first manifestation of onset.

18

Even trying to give some meaning to the word

19

"first" in the table period is difficult, given the way

20

the court of appeals interpreted that phrase, because if

21

Congress had set out to do what the court of appeals had

22

done, it wouldn't have needed to use the word "first" at

23

all.

24

administration, because any symptom is always first in

25

relation to what came -- comes after the statutory period.

It could have just said, any symptom after vaccine

6

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

The only real reason to use the word "first" is

2

to make clear that you're talking about first in relation

3

to what came before the statutory period.
But whatever ambiguity you have when you just

4
5

look at this language, I think the bigger problem with

6

what the court of appeals did is that it looked here at

7

all, because the purpose of the Vaccine Injury Table is

8

not to set out what the claimant is required to show in

9

order to trigger the statutory presumption.

It's set out

10

to show the time period in which the claimant has to make

11

that showing.
QUESTION:

12

Isn't the term "first" somewhat

13

superfluous with the term "onset"?

14

MR. GORNSTEIN:

Well, I think you have the first

15

symptom or manifestation of onset, or significant

16

aggravation.

17
18
19

QUESTION:

So first doesn't modify onset, in

your view?
MR. GORNSTEIN:

I think it -- it does modify

20

onset, yes, but I think it's just first symptom or

21

manifest -- it's somewhat superfluous, I would agree, but

22

I think it makes it more clear.

23

relationship between "first" and "onset."

It describes a

24

So I think that that is the basic mistake, is in

25

looking to the Vaccine Injury Table, because what -- under
7
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

section 300aa-13, it tells you that compensation is

2

appropriate when the petitioner has demonstrated the

3

matters in 300aa-ll, and 300aa-ll is the part of the

4

statute we're relying on, which is very clear, and I

5

believe even the court of appeals acknowledged that when

6

you look at 300aa-ll, it's very clear that the claimant

7

has to show, in effect, the first of all manifestations.

8

QUESTION:

Mr. Gornstein, if we were to agree

with you on the interpretation of the statute as to
10

question 1 in the cert petition, do we need to reach the

11

question of the standards under question 2, as posed in

12

the cert position?

13

MR. GORNSTEIN:

You do not.

We have presented

14

both questions because we think that in this case one or

15

the other has to be suffic -- there are two independent

16

grounds, and either one will do.

17

QUESTION:

The respondent spends a good deal of

18

time discussing how the district court might have reached

1

the wrong conclusion on the facts here.

20

those matters are open on remand.

21

22

MR. GORNSTEIN:

25

We would agree that those

matters are open on remand.

23
24

I assume all of

If there are no further questions on the
first -QUESTION:

I have one.

What was the first

8

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)28 -2260
(800) FOR DEPO

1

symptom?
MR. GORNSTEIN:

2

The first symptom or

3

manifestation was the abnormally small head size at birth,

4

which was -- the special master found was a positive

5

indication that this child was -- already had a very

6

serious brain injury.

7

The second clear manifestation occurred at

8

between 3 and 4 months, and that was the fact that she

9

fell further behind on the growth chart in head size, and

10

so that was also, the special master said, a manifestation

11

that she had a preexisting brain injury, serious brain

12

injury.

13

QUESTION:

Is there any question in the record,

14

just as an evidentiary matter, that the head size can be

15

treated as a cause of the brain injury?

16

MR. GORNSTEIN:

I would say it's not the head

17

size that's the cause, it is the abnormally small brain

18

that is the cause of the injury, and it is the abnormally

19

small head size that tells you you have an abnormally

20

small brain, and sometimes the term microcephaly is used

21

to refer to both of those things, but what you have is an

22

abnormally small head size that tells you you have an

23

abnormally small brain, and that's what the special master

24

found.

25

QUESTION:

So there's no question about the
9

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

evidentiary basis for that relationship.

2

MR. GORNSTEIN:

3

QUESTION:

4

No.

If we therefore reverse, there's not

going to be a fight over what the evidence shows.
MR. GORNSTEIN:

5

Well, the other side may have a

6

different view on whether the kind of - - the head size

7

here was sufficiently indicative of an abnormally small

8

brain, the kind of abnormally small brain that would

9

result in the conditions, and that was the dispute that

10

was had at trial.
The special master resolved that by finding that

11
12

there was sufficient evidence that it was so abnormally

13

small as to indicate abnormally small brain that would

14

give rise to these conditions.

15

QUESTION:

You say there's no question about the

16

evidentiary basis for that finding.

17

MR. GORNSTEIN:

I think that's clearly

18

supportable in the evidence.

19

disturb the special master's findings on that, and in

20

answer to Justice O'Connor's question, I was simply saying

21

that that is open on remand for them to argue that there's

22

something wrong with that finding.

23

is.

24
25

QUESTION:

The court of appeals did not

We don't think there

Is the difference in the two

briefs -- you refer to a scientific term, and the
10

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

plaintiffs refer to small head, not conceding that that

2

was any kind of symptom of any malady.

3

dispute - MR. GORNSTEIN:

4

Is that what the

I think that's the factual

5

dispute, that the head -- they would agree, I believe,

6

that at some point the head size is so small as to let you

7

know that there is a real problem and that brain injury

8

has already occurred, but they'll have to speak for

9

themselves on that issue, but I think what they would say

10

is, it wasn't small enough, and that the special master

11

heard conflicting evidence about that and concluded that

12

it was.

13

He also concluded -- really, the main dispute

14

was at birth, but there was really no -- what was even

15

clearer evidence is the further fall-off below the second

16

percentile that occurred between the third and fourth

17

month.

18

indication that some serious brain injury had occurred at

19

3 months, no later than 3 months.

20

at birth.

21

Even their expert agreed that that was an

QUESTION:

It could have occurred

Well, let me ask you, and perhaps

22

this will bring you to your second point, was it the

23

hearing examiner's theory -- is it the Government's theory

24

that the ultimate condition, the encephalopathy, was

25

related to the microcephaly?
11

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

MR. GORNSTEIN:

1

Yes, that's right, that the

2

abnormally small brain led to the difficulties that this

3

child later experienced in life, including mental

4

retardation, and cerebral palsy, that these are, in fact,

5

children with microcephaly, over 90 percent turn out to

6

have -- are mentally retarded.

7

percentage that are not.
QUESTION:

8

9
10

There's only a small

And is that the reason --or perhaps

there are other reasons.

Is that the reason that the

ultimate condition is not idiopathic?
MR. GORNSTEIN:

11

The reason that the ultimate

12

condition is nonidiopathic is that we take a different

13

view of what that term means than did the court of

14

appeals.

15

the Secretary saying something like, we know, we have

16

evidence that the vaccine did not cause the child's

17

condition, but we have no idea what did.

18

We think that what not idiopathic rules out is

The court of appeals took that one step further

19

back and said, even if we can identify a factor that

20

caused the child's condition, we then have to go back and

21

show what caused that factor, effectively requiring a dual

22

layer of causation.

23

So it wasn't enough for the Government to show

24

that the small brain, abnormally small brain led to the

25

child's condition unless the Government can then go back
12

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

and show what caused the child to have a small, abnormally

2

small brain size in the first place.
QUESTION:

3

So are you saying that you can

4

concede that the microcephaly is idiopathic, in the sense

5

that we don't know what caused it, but that you still

6

prevail in this case?

7

MR. GORNSTEIN:

That's right, because I think

8

idiopathic within the meaning of this statute simply -- it

9

describes a situation where the Secretary says, I have

10

no - - the vaccine couldn't have caused it.

11

what did.

12

That's not this case.

I have no idea

The Secretary is saying,

13

we know what caused the child's condition.

14

preexisting microcephaly, or abnormally small brain.

15

just don't know what caused that.

16

QUESTION:

It is the
We

So idiopathic depends on the question

17

we're asking, I take it.

18

MR. GORNSTEIN:

That's exactly right, and I

19

think that to resolve that ambiguity I think you should go

20

back to the core language in section 300aa-13, which says

21

that the Secretary --

22

can rebut the presumption of causation by showing that the

23

child's condition is due to factors unrelated to the

24

administration of that vaccine.

25

(b), that shows that the Secretary

When you just read that language, you definitely
13
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

get the sense that the Secretary can rebut the presumption

2

of causation by showing an alternative cause, but nothing

3

in that would require the Secretary to establish the cause

4

of the cause, and I think when you move down to the later

5

references to idiopathic, you should -- and unknown, you

6

should read them in light of that basic distinction.

7

What must be known is the cause, not the cause

8

of the cause, and the purpose of this idiopathic provision

9

was to clear up an ambiguity that would otherwise have

10

existed if they had just said, factors unrelated to the

11

administration of the vaccine, because at that point it

12

might have been the case that the Secretary could have

13

said, I know the vaccine didn't cause it.

14

to prove it.

15

unrelated did.

16

I have evidence

I don't know what did, but a factor

QUESTION:

Does the medical profession use the

17

word, idiopathic, in the same sense that we're using it

18

here, relative depending on which question we're asking?

19

MR. GORNSTEIN:

I think that's right.

I can't

20

say that's 100 percent true, but I think they would

21

describe -- they could easily describe it either way,

22

depending on the question you're trying to answer.

23

QUESTION:

Does your under -- does sense of

24

idiopathic, as you are saying the statute uses it, broad

25

enough to cover this situation:

is a condition idiopathic

14

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

when that condition is part of a recognized disease, in

2

and of itself, although we don't know what causes the

3

disease?
For example, if you had a vaccine, one of the

4
5

symptoms of which is people get -- sometimes get forgetful

6

after a couple of days, and someone with Alzheimer's

7

disease had the vaccine and was indeed forgetful.

8

wouldn't say, in effect, I suppose, that Alzheimer's

9

disease causes forgetfulness.

We

That's what we mean by

10

Alzheimer's disease, so in that case, if the Secretary

11

came in with evidence there was preexisting Alzheimer's

12

disease, would that be sufficient for rebuttal under your

13

understanding of idiopathic?

14

MR. GORNSTEIN:

15

the Alzheimer's preexisted the --

16

QUESTION:

17

MR. GORNSTEIN:

18

vaccine, yes, because --

19

QUESTION:

As long as you could show that

Yes.
-- the administration of the

So nothing is idiopathic, then, I

20

guess, if it is a condition which is sort of a recognized

21

set of symptoms or conditions within normal diagnostic

22

practice.

23

MR. GORNSTEIN:

That's right, and cancer would

24

be a good example.

25

you knew that led to certain brain problems, mental

If you had a preexisting cancer, and

15
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

retardation or whatever, even if the cancer was idiopathic

2

in the sense that we don't know what caused the cancer,

3

it's not idiopathic within the meaning of the statute,

4

because it is a specific factor that the Secretary is

5

relying on to explain the child's condition.

6

Secretary would not be saying in that case, I have no idea

7

what caused this child's condition.
The one other reason that I would give in

8

9

The

support of our interpretation, other than the statutory

10

language that I relied on, is that the court of appeals'

11

interpretation is really inconsistent with the purposes of

12

the compensation program, because by adding a second layer

13

of causation, they are really requiring compensation in

14

cases in which everyone would agree that the vaccine could

15

not have caused the child's condition because something

16

else did.

17

limit compensation to vaccine-related injuries.

18
19

That is not consistent with Congress' intent to

If the Court has nothing else, I'll reserve the
balance of my time for rebuttal.

20

QUESTION:

21

Mr. Moxley, we'll hear from you.

22

ORAL ARGUMENT OF RICHARD THOMAS MOXLEY

23

ON BEHALF OF THE RESPONDENTS

24
25

MR. MOXLEY:

Very well, Mr. Gornstein.

Mr. Chief Justice, and may it

please the Court:
16
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

On behalf of Maggie Whitecotton, we are not

1

2

contending for a departure from the court of appeals

3

decision, nor are we contending for a rule based on a

4

generous interpretation of the statute, nor are we

5

contending for an interpretation of the statute.
We are contending for an enforcement of the

6

7

express language of section 300aa-13(a)(2)(A), found at

8

page 3 of the petitioner's brief, which states that the

9

term "factors unrelated to the administration of the

10

vaccine" does not include any idiopathic, unknown,

11

hypothetical, or undocumentable cause, factor, injury,

12

illness, or condition.

13

On the subject of microcephaly, we do not

14

believe that microcephaly qualifies as a first symptom of

15

encephalopathy.

16

outside of the head at its largest point.

17

measure of the function of the brain inside.

18

measurement is always in measuring it too small, because

19

the largest part of the head is what the doctor looks for.

Microcephaly is the measure of the
It's not a
Any error in

20

Microcephaly is not a diagnosis.

21

disease any more than short stature is a symptom of

22

disease.

23

QUESTION:

It is not a

Isn't that a matter, counsel, for

24

medical judgment, and weren't there expert witnesses who

25

testified that that was a manifestation, or symptom, of
17
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

the ultimate disability?
MR. MOXLEY:

2

Correctly stated, no medical

3

authority would consider it to be a symptom.

4

stated, a medical authority would consider it to be a

5

finding, and to call it a symptom is to be sloppy in the

6

use of the language.

7

QUESTION:

Well, what did the experts who

8

testified in this case call it?

9

MR. MOXLEY:

10

Correctly

I cannot recall, Your Honor, that

experts ever called it a symptom, as such.
In the context of the statute, the statute

11
12

prescribes what symptoms of encephalopathy are.

13

symptoms of encephalopathy are set forth extensively in

14

section 14(b)(3)(A), the age and qualifications to the

15

interpretation of the Vaccine Injury Table, and proof of

16

an encephalopathy, in table time at least, or even outside

17

of table time, under that statute is very narrow, and it

18

focuses on specific medical findings such as EEG, such as

19

bulging fontanel, it even says that the classical signs of

20

a DPT reaction are compatible with but not proof of an

21

encephalopathy, so -QUESTION:

22

23

Are they recited

to be exclusive?

24
25

Are they exclusive?

The

MR. MOXLEY:

They are not exclusive, but I don't

believe -18
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

QUESTION:

1

So what difference does it here

2

whether it's called a symptom or anything else?

3

understand it, the finding below was that there was a

4

pathological condition of the brain which was evidenced by

5

the small head size, if you like, but --

6

MR. MOXLEY:

7

QUESTION:

As I

That is correct --- but that there was that

8

pathological condition before the vaccine was

9

administered, and that's what needs to be proven, isn't

10
11

it?
MR. MOXLEY:

Well, what we believe this Court

12

should do is articulate a rule which will guide us in our

13

practice, and we believe the enforcement of the plain

14

language of the statute sets forth a sequence of analysis

15

that must be performed.

16

master did was skipped a step in the sequence.

17

sequence in the statute is first, 13(a)(1)(A), and then

18

13 (a) (1) (B) .

19

We believe that what the special
The

13(a)(1)(A) first calls for the inquiry as to

20

whether or not the petitioner has proven a table case.

21

this case, the proof of this case, in the Government's

22

proof of this case, the Government used the table reaction

23

as part and parcel of the proof of the preexisting

24

condition, and the special master skipped over the table

25

reaction to get into the causation inquiry before the
19
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

In

1

special master made the findings that give us the benefit

2

of the presumption.

3

QUESTION:

4
5
6

7

But that wasn't the basis for the

court of appeals ruling, was it?
MR. MOXLEY:

In a very strong sense, Your Honor,

I believe it is.
QUESTION:

Well, the court of appeals -- I

8

understood the court of appeals to leave the findings of

9

the special master undisturbed.

10

MR. MOXLEY:

I agree that that happened,

11

although the special master did violence to the statute,

12

and the court of appeals was able to determine the case in

13

that -- because of that legal error.

14

We believe the court of appeals said what they

15

can't do, but we believe that this Court should set forth

16

a rule telling us what they can do, and we believe that

17

the proof - -

18

19

QUESTION:

Are you defending the reasoning of

the court of appeals here?

20

MR. MOXLEY:

21

QUESTION:

Oh, very much so, Your Honor.
Well, but since the court of appeals

22

dealt virtually not at all with the findings of the

23

special master, I don't see why you should concentrate on

24

the findings of the special master, then.

25

MR. MOXLEY:

Oh, I don't so much focus on the
20

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

findings, Your Honor, as the process which the special

2

master went through, and the special master skipped over

3

the finding of the table injury.
The special master found, parenthetically, as it

4
5

were, that technically the petitioners had put on a table

6

case.

7

a focus on the table time injury.

8

statement of the questions presented, we believe that the

9

Secretary must prove through a logical sequence of cause

Our strongest argument is that the statute requires
As implied by our

10

and effect that the so-called factor unrelated can be

11

shown as the cause of the table injury.
In this case, the special master's analysis was

12

13

whether or not the so-called factor unrelated was

14

consistent with the ultimate outcome.

15

We believe it would be legally and logically

16

inconsistent to allow the Government to use the same facts

17

which give rise to the presumption to also defeat the

18

presumption, and the Government syllogism of causation in

19

this case was that this child had to have an organic brain

20

syndrome because this child had a small head, and this

21

child had seizures, and this child had cerebral palsy, et

22

cetera.

23

QUESTION:

Well, let's look at (a)(1)(A).

24

That's what you say was not adequately done.

25

a showing of the matters required by section
21

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

It requires

1

300aa(ll)(c)(1).

Where is that?

MR. MOXLEY:

2

11(c)(1) is the statute found at

3

page 4 of the petitioner's brief.

4

forth the requirements of the petition that -QUESTION:

5
6

The bottom of page 4, Vaccine Injury

Table, is that what you're talking about?

7

MR. MOXLEY:

No, it -- the requirements of the

8

petition.

9

contain documentation.

MR. MOXLEY:

QUESTION:

15

MR. MOXLEY:

16

QUESTION:

18

I - - the statute is on page 3, I'm

sorry.

14

17

Where are you reading from,

Mr. Moxley?

12

13

The -- 11(c)(1)(C)(i) says a petition shall

QUESTION:

10

11

11(c)(1) merely sets

Page 3 -Of the petitioner's brief.
-- of the petitioner's brief, thank

you.
MR. MOXLEY:

Page 2.

Page 2 is section 11.

19

says, the petition shall contain documentation that the

20

person who suffered such injury sustained or had

21

significantly aggravated any illness set forth in the

22

Vaccine Injury Table, and the first symptom or

23

manifestation of the onset or significant aggravation

24

occurred within the time set forth in the table.

25

Now, it's -22

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

It

QUESTION:

1

And it goes on, and the first symptom

2

or manifestation of the onset or of the significant

3

aggravation of any such illness, disability, blah, blah,

4

blah, blah, blah.

5

MR. MOXLEY:

6

QUESTION:

7

Now --

Don't leave that out.

That's central

to the case, isn't it?
MR. MOXLEY:

8

9

Yes.

Well, the thing that -- I agree,

yes, Your Honor.

10

The matter that is central to the case is that

11

what happened to Maggie Whitecotton in table time is the

12

onset of a table condition, a residual seizure disorder.

13
14

QUESTION:

Well, but that's the debate.

mean - -

15

MR. MOXLEY:

16

QUESTION:

17
18

I

Well, the special master --- you simply just can't say that the

special master ignored that provision.
MR. MOXLEY:

The special master found, Your

19

Honor, that the child technically,

20

the provisions of the table with regard to a residual

21

seizure disorder.

22

occurred in table time.

That is, the child's first seizure

23

QUESTION:

24

MR. MOXLEY:

25

"technically" satisfied

But -That has to be the onset of a

significant aggravation.

As a matter of law, a table
23

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

injury, ab initio, in table time, has to be something that

2

satisfies the table.
QUESTION:

3

But the illness is not the seizure.

4

Surely the seizure is a manifestation of an illness, isn't

5

it?

6

is, he has --

7
8

9

Is the seizure the illness?

MR. MOXLEY:

You ask what his illness

The encephalopathy, the acute

encephalopathy -QUESTION:

10

MR. MOXLEY:

11

QUESTION:

All right.
-- was the injury, Your Honor, yes.
All right, and what this requires is

12

that the first symptom or manifestation of the onset or of

13

the significant aggravation of the illness have occurred

14

within the period after the vaccine --

15

MR. MOXLEY:

16

QUESTION:

17

MR. MOXLEY:

18

QUESTION:

19

MR. MOXLEY:

Yes, Your Honor, but --- was administered.
A residual seizure disorder -And that's what the debate is about.
A residual seizure disorder is a

20

table injury and it is a specific table injury, and it is

21

a specific species of table injury, and it's also the most

22

specific well-known species of vaccine injury.

23

QUESTION:

But counsel, the special master found

24

that the child had not, in fact, suffered a residual

25

seizure disorder, and you didn't petition for cert on
24
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.VJ.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

that.

I didn't think that was before us here.
The CA Fed has not addressed that, has it?

2

3

I

just didn't think that argument was even here.
MR. MOXLEY:

4

Your Honor, I believe the CA Fed

5

recognized that the seizure, under the statute, was

6

clearly the onset, the first onset of symptomatic

7

encephalopathy, and I believe that's a correct holding.
QUESTION:

8

Yes, but you were just arguing this

residual seizure disorder point, and I understood that
10

that issue was not here.

11

the special master, and it isn't here.
MR. MOXLEY:

12

It was decided against you by

The special master did say that the

13

child suffered a residual seizure disorder.

14

master said that the child doesn't now suffer from a

15

residual seizure disorder.

16

of, Your Honor, is the fact that a residual seizure

17

disorder and an encephalopathy are overlapping

18

definitions, and the residual seizure disorder is in the

1

table to satisfy by itself the requirements of the table

20

to show a table time encephalopathy.

The special

What that doesn't take account

The CA Fed showed that the child - - held that

21
22

the child had suffered a table time encephalopathy, and I

23

don't think anybody factually disputes that.

24
25

QUESTION:

Did the special master hear medical

evidence?
25
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)28 -2260
(800) FOR DEPO

MR. MOXLEY:

1

The special master did, Your Honor.

2

The special master synthesized his findings from the

3

literature, and we submit that they are not the type of

4

finding to be given deference by an appellate court

5

because they are logically absurd on their face.
If 90 percent of the children with this head

6

7

size had seizure disorders --

8

QUESTION:

9

point, my impression was the findings simply are not here.

10

MR. MOXLEY:

11

QUESTION:

12

MR. MOXLEY:

13

But to repeat Justice O'Connor's

I agree that we're not arguing -But you keep criticizing them.
I understand that, Your Honor.

Our - -

14

QUESTION:

You agree, I take it, that there can

15

be different kinds of symptoms evidencing the same cause,

16

right, evidencing the same disease.

17

more than one symptom, right?
MR. MOXLEY:

18

19

A disease can have

Many manifestations, yes, Your

Honor.
QUESTION:

20

Now, suppose that a symptom of

21

encephalopathy occurred before the administration of the

22

vaccine.

23

MR. MOXLEY:

24

QUESTION:

25

Yes, Your Honor.
The presumption would not be

satisfied then, would it?
26
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

2

I don't agree with that,

Your Honor, because -QUESTION:

3
4

I -- no,

MR. MOXLEY:

1

All right.

I think that's what we're

here to argue about.

5

MR. MOXLEY:

6

QUESTION:

Yes.

The issue -- the issue --

And I think it would assist the Court

7

if you would argue that point, because that's where you're

8

in disagreement with the Government, and that's why the

9

case is here.
MR. MOXLEY:

10

Yes, Your Honor.

The issue is

11

whether or not an acute encephalopathy occurs within table

12

time.

13

is whether or not that acute encephalopathy radically

14

changes that child's future prognosis.

15

encephalopathy does radically change that child's future

16

prognosis, that child has had a significant aggravation.

If the child has a preexisting condition, the focus

17

If the

There is no way to trigger the significant

18

aggravation presumption other than to have an acute

19

encephalopathy in table time, and the sudden onset of

20

seizures in table time, and the diagnosis in the record by

21

the treating physicians of a DPT encephalopathy,

22

that burden whether or not the child had a preexisting

23

condition.

24
25

QUESTION:

Well,

satisfies

it's necessary to satisfy the

burden, but it's not sufficient to satisfy the burden,
27
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

because you've also got to show that it was -- that these

2

symptoms were the manifestations, the first manifestations

3

of the onset of the disease, and that in and of itself

4

doesn't follow merely from introducing evidence that after

5

the vaccination the symptoms occurred.

6

introduce something else, haven't you?

7

MR. MOXLEY:

You've got to

I don't exactly agree with that,

8

Your Honor.

9

disease, the alleged disease necessarily includes the

10

The issue is -- is whether or not the

symptoms.
All are in agreement that the alleged organic

11
12

brain syndrome which allegedly preexisted the table time

13

reaction, all are in agreement that the table time

14

reaction is not typical of organic brain syndrome.

15

are in agreement that seizures are not typical of organic

16

brain syndrome.

17

is not necessarily a manifestation of organic brain

18

syndrome.

19

All

All are in agreement that cerebral palsy

QUESTION:

Well, they may not be typical, but if

20

in fact the evidence is that they were caused, and you

21

don't also introduce some evidence to the effect that

22

there was no other manifestation of the disease prior to

23

vaccination, you haven't touched all the bases required in

24

the statute, have you?

25

MR. MOXLEY:

I believe that -- I believe it gets
28

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

2

3
4

back to 13 (a) (2) (A) .
QUESTION:

Well, what's the answer to my

question first?
MR. MOXLEY:

The answer is that there was --

5

that microcephaly is not a disease.

6

a symptom of a disease.

7

not a disease, either.

8

is totally speculative.

9

QUESTION:

Microcephaly might be

Chronic organic brain syndrome is
It is an idiopathic disorder.

Well, no one is claiming in this case

10

that microcephaly is itself the disease.

11

maybe I'm missing your point --

12

MR. MOXLEY:

13

QUESTION:

14

It

I mean, I --

I believe the Government has.
-- but I don't think that responds

either to the Government's position or to my question.

15

MR. MOXLEY:

16

QUESTION:

I believe, Your Honor -I thought the disease was

17

encephalopathy, and the Government is simply saying

18

that -- well, I -- strike what the Government is saying.

19

It seems to me that in order to make the case

20

that you have to make in the first instance, you would

21

have to show not merely that there was some manifestation,

22

some symptoms of that following the vaccination, but that

23

in fact it was the first symptom, that it was the symptom

24

of an onset, and if you don't show that, you haven't, in

25

fact, made out your prima facie case, isn't that so?
29
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

MR. MOXLEY:

1

I don't believe that it has to be

2

the first symptom in a significant aggravation case.

3

legislative intent has a specific -- fact-specific example

4

in it of the aggravation of a seizure disorder, and all it

5

requires is that the seizures become more frequent, so the

6

first --

7

QUESTION:

The

Let's say it's not a -- let's leave

8

aside the aggravation point.

If you're just talking about

9

the first symptom of the illness, then you would agree

10

that you must show not only that there was a symptom

11

within the table time after the vaccination, but that it

12

was the first symptom.

13
14
15
16
17

MR. MOXLEY:

That is correct for what we call an

onset case, Your Honor, yes.
QUESTION:

I don't dispute that at all.

Your position is that this is an

aggravation case, is that correct?
MR. MOXLEY:

Our position is that this case

18

satisfies the table presumption for significant

19

aggravation.

20

QUESTION:

So that if I understand you correctly

21

that even though there might have been a symptom of the

22

disease before the vaccination, therefore it's not --

23

therefore what happened after the vaccination is not the

24

first symptom of the onset, nevertheless, I understand

25

your position, there could be a serious aggravation caused
30
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

by the vaccine, and the first symptom of that was the

2

seizure within 3 days.

3
4

MR. MOXLEY:
The - -

5
6

That is correct, Your Honor.

QUESTION:

So that if there -- but that's not

the theory of the court of appeals, or am I right on that?

7

MR. MOXLEY:

Well, it's both.

Our theory is

8

that we had actually the first symptom of an

9

encephalopathy as defined by the act in table time after

10

the shot.

11
12

QUESTION:

You make two arguments.

1) you say

the small head size is not a symptom.

13

MR. MOXLEY:

14

QUESTION:

Yes.
That's one of your arguments.

And

15

alternatively you argue, under the table, that the seizure

16

within 3 days, or whatever the period was, was the first

17

symptom of a serious aggravation.

18

MR. MOXLEY:

19

QUESTION:

20

So you have two alternative

arguments â€¢

21

MR. MOXLEY:

22

QUESTION:

23

That is correct, Your Honor.

That is correct.
What did the finder of fact conclude

as to that?

24

MR. MOXLEY:

25

QUESTION:

The finder -I mean, surely that's a factual
31

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

2

question.
MR. MOXLEY:

The finder of fact found that we

3

technically fit the table, but that maybe Congress did not

4

intend for the table to be literally applied.

5

QUESTION:

Can you point to the words in the

6

finder of fact's findings that say what you've just

7

summarized?

8

9

MR. MOXLEY:

There is a footnote.

have to look in the petition for writ, and have to look

10

for the special master's decision.

11

petition for writ of certiorari.

12

One would

Page 27a of the

The special master found that the child's

13

condition satisfied the injury table but that he did not

14

have to find a table injury, and footnote 4, he said his

15

conclusion was based on a literal reading.

16

Congress may have intended something else.

17

However,

We believe that we need a rule that will govern

18

us in our practice.

19

puts the burden on the Government after we satisfy our

20

burden, and does not put a burden on us to disprove the

21

Government's case in the satisfaction of our burden.

22

23
24
25

QUESTION:

We believe that we need a rule which

If you need a rule, I mean, I thought

this case came here on a slightly different theory.
Imagine a baby is born.
has a seizure.

On the 3rd February it

On the 3rd March, it has another seizure.
32

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

On the 1st April it gets some DPT vaccine, and on the 3rd,

2

it has a third seizure.
In that circumstance, I thought the statute

3
4

makes clear that you have not -- will not be able to

5

recover.

6

MR. MOXLEY:

7

QUESTION:

It doesn't -You were not able, in that situation,

8

to show what, I guess, the statute here in 11(c) requires,

9

that you have to show that -- what are the exact words,

10

that the first symptom or manifestation of the injury or

11

the aggravation occurred within 3 days after the DPT

12

vaccine.

13

MR. MOXLEY:

14

QUESTION:

I agree, Your Honor.
And yet the Fed Circuit seemed not to

15

do that simple thing.

16

even if it were just the case I was describing, that that

17

words wouldn't apply.

18

Rather, they seemed to say that

That's what I thought the issue was initially,

19

and then that seems to be mixed up with a different issue,

20

is, is this small head size like the prevaccine seizures

21

or not like the prevaccine seizures?

22

it wasn't a symptom or manifestation, and I guess

23

initially the other side said it was.

24

MR. MOXLEY:

25

QUESTION:

You're saying not,

Am I right?

You are.
If not, explain why I'm not.
33

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

Am I --

1

I am right?

2

MR. MOXLEY:

3

QUESTION:

4

MR. MOXLEY:

The thing that would have to be -I'd like to be right.
Yes, Your Honor.

The thing that

5

would have to be added to your significant aggravation

6

scenario --

7

QUESTION:

8

MR. MOXLEY:

9

Yes.
-- in order for us to satisfy our

case to show -- our burden to show a table case would be

10

for that seizure after the shot to be the first of weekly

11

seizures.
QUESTION:

12

There'd have to be some change.

In

13

the pure case that I imagine, everybody's in agreement.

14

Is that right?

15

MR. MOXLEY:

16

QUESTION:

I believe so, yes.
And so then the question is, was it

17

somehow an aggravation, a symptom of a significant

18

aggravation, the first symptom of a significant

19

aggravation --

20

MR. MOXLEY:

21

QUESTION:

Yes, Your Honor.
-- and if so, the statute seems to

22

say, if it's the first symptom of the significant

23

aggravation -- that's what -- the words it uses, then, if

24

you show that, you prevail, but then what's the legal

25

argument?
34
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

They're saying, and as it comes up here, it

1

2

seems as if there is a finding that it isn't the first

3

symptom of a significant aggravation.

4

here that preexisted, and there was no significant change.

5

Those are fact-findings.
MR. MOXLEY:

6

There was a disease

Your Honor, in the -- there's a

7

legal standard there that's implicit.

The Office of

8

Special Masters has articulated a presumption of normalcy
for the child at the time of the shot if the child has had

10

no overt symptoms of encephalopathy, and if you'll look at

11

the Government's reply brief, they would put the burden on

12

us of proving that the child was normal at the time of the

13

shot, and we believe that we need an articulation of what

14

this statute means in terms of what it means to our

15

practice, and we believe that the Court should find that

16

this child has the right to be presumed to be normal if

17

she had no symptoms of encephalopathy that fit the

18

statute --

1

QUESTION:

Well, what the statute says, the

20

statute says that you, the petitioner, have to demonstrate

21

by a preponderance of evidence matters in the petition, in

22

300aa(ll)(c)(1).

23

symptom or manifestation of the significant aggravation

24

occurred within 3 days after the DPT vaccine, so it would

25

seem to say that you have to show that.

One of those matters is that the first

35
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)28 -2260
(800) FOR DEPO

So why wouldn't

1

2

it?
MR. MOXLEY:

Well, the first symptom does not

3

require a showing that the child was normal.

4

symptom is the first symptom.

5

was, indeed, the first symptom.

6

Microcephaly is not a symptom.

7

QUESTION:

The first

The seizure in this case
There were no symptoms.

Mr. Moxley, may I come back to

8

Justice Ginsburg's question about what the finder of fact

9

had to say about aggravation?

10

You referred us to page 27a, and footnote 4.

I

11

have read it now three times, and I find not a word about

12

aggravation.

13

It says nothing about aggravation.

MR. MOXLEY:

The special master went into the

14

question of comparing the ultimate condition, consistency

15

of ultimate conditions.

16

QUESTION:

This is the closest you can find to a

17

finding by the special master that this was a significant

18

aggravation --

19

MR. MOXLEY:

20

QUESTION:

21

MR. MOXLEY:

22

QUESTION:

23

MR. MOXLEY:

24

QUESTION:

25

No, Your Honor.
Page 27a.
No, Your Honor.
Well, give me another page.
That is the -I don't find a mention of aggravation

on page 27.
36
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

MR. MOXLEY:

2

QUESTION:

3

I agree.

I --

Well then, why did you cite that page

in response to Justice Ginsburg's question?
MR. MOXLEY:

4

I believe that she was asking me if

5

I was -- if I could point out whether or not the Court had

6

addressed the issue of a table injury, Your Honor.

7

QUESTION:

8

MR. MOXLEY:

9

QUESTION:

10

I thought it was aggravation.
I believe that -Well, I'll ask you.

Aggravation.

What did the - -

11

(Laughter.)

12

QUESTION:

What did the finder of fact have

13

to -- you're contending this was an aggravation.

14

did the finder of fact find an aggravation?

15

MR. MOXLEY:

Where

The finder of fact used the Massoci

16

test as articulated --as ostensibly argued in my brief,

17

which was to compare the ultimate condition of the

18

speculative -- compare the ultimate condition to the

19

outcome from the speculative organic brain syndrome.
Because the special master focused on the final

20
21

outcome rather than on the table injury, the special

22

master was able to find that the causation of the ultimate

23

outcome was from the speculative hypothetical preexisting

24

condition.

25

QUESTION:

I think what you're saying is, not at
37

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

all.
MR. MOXLEY:

2
3

Not at all, properly.

correct, your Honor.

4

QUESTION:

5

did not find any aggravation.
No.

He addressed aggravation at

page 36a --

8

QUESTION:

9

MR. MOXLEY:

10

Not at all, that the finder of fact

MR. MOXLEY:

6
7

That is

Ah.
--of that same -- in that same

opinion.

11

QUESTION:

12

MR. MOXLEY:

All right.
A comparison of the condition prior

13

to the administration of the vaccine and an exercise of

14

deciding whether or not that condition was consistent with

15

the current condition.

16

brain-injured prior to the shot, there's a way of saying

17

that the ultimate condition is always consistent --

18
19

QUESTION:

Where on 36a does the special master

talk factually about aggravation?

20
21

If you believe that the child is

MR. MOXLEY:
did.

22

I don't believe the special master

I don't believe the special -QUESTION:

Did the special master anywhere make

23

any factual finding that there was an aggravation?

24

no.

25

MR. MOXLEY:

No.

Yes or

He found that there was no
38

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

aggravation.

The issue to us is whether or not the table

2

condition itself is an aggravation, and the special

3

master's analysis is whether or not the ultimate condition

4

is an aggravation, and we believe that it strips us of the

5

statutory presumption of compensability -QUESTION:

6

Mr. Moxley, in answer to the question

7

that was asked, I think that there was something the factÂ­

8

finder said.

9

significant aggravation of Maggie's underlying brain

He said -- this is on page 43a -- "no

10

disorder was manifested within 3 days following the

11

administration of the DPT vaccine," so he made a finding

12

that there was no significant aggravation.

13
14

MR. MOXLEY:

I agree, Your Honor.

I believe

that the onset of a residual seizure disorder in the --

15

QUESTION:

Mr. Moxley, we've been questioning

16

you several times about findings of aggravation.

17

answered me just a moment ago that the special master made

18

no finding.

19

a very express finding.

20

rostrum and give these totally inconsistent answers?

22

Now Justice Ginsburg points out that he made

MR. MOXLEY:

21

You

How can you stand up there at the

I'm sorry, Your Honor.

I don't

mean - -

23

QUESTION:

24

MR. MOXLEY:

.25

QUESTION:

Well, you should be.
I don't mean to confuse the Court.
Well, you -- perhaps you haven't
39

ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

confused us so much as just made us gravely wonder, you

2

know, how well-prepared you are for this argument.
MR. MOXLEY:

3

Your Honor, it is our assertion

4

that the onset of a residual seizure disorder in table

5

time is a significant --

6

QUESTION:

7

MR. MOXLEY:

8

Thank you, Your Honor.

9

QUESTION:

10

Your time has expired.
-- aggravation as a matter of law.

Mr. Gornstein, you have 11 minutes

remaining.

11

REBUTTAL ARGUMENT OF IRVING L. GORNSTEIN

12

ON BEHALF OF THE PETITIONER
MR. GORNSTEIN:

13

Just two quick points.

One is

14

that the court of appeals did not reach the question of

15

significant aggravation.

16

case, and that's clear from page 5a of our -- to the

17

petition for a writ of certiorari, where they quote the

18

language from the table that refers to onset.

19

QUESTION:

It decided this case as an onset

It is correct, is it not, that your

20

opponent does rely in part on it being an aggravation

21

case?

22

MR. GORNSTEIN:

Yes, and I was going to say that

23

the special master found that there was no significant

24

aggravation.

25

support of that.

There is a discussion of the evidence in

40
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

QUESTION:

The theory of the special master was,

2

you compare the condition at the time of the vaccination

3

with the condition in the long run, as I understand it.

4
5
6

7

MR. GORNSTEIN:
of the analysis.
QUESTION:

And your opponent's argument is that

the seizure itself was an aggravation, isn't that right?

8

MR. GORNSTEIN:

9

QUESTION:

10
11

I would say that that was part

That's their theory, and I --

And that's what the table -- that's

the theory of the table under his view of the statute.
MR. GORNSTEIN:

His theory was that the seizure

12

was the manifestation of a significant aggravation, and

13

the special master addressed that and said that it wasn't

14

because the seizures were very brief and transient, that

15

after the seizures in the table period, that the child

16

returned to her prevaccine neurological status, that she

17

continued to progress at the basically kind of slow but

18

sure pace, and that she ultimately --

19
20
21

22

23

QUESTION:

Is it correct that the seizure --as

to the first seizure the child had?
MR. GORNSTEIN:

That is the first seizure the

child had, yes.
QUESTION:

So at least there's an argument that

24

hasn't been resolved by the courts below as to whether

25

that might itself satisfy the requirements of the table.
41
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

MR. GORNSTEIN:

1

2

Well, two of the three courts

below resolved it, but the court of appeals did not.

3

QUESTION:

Right.

4

MR. GORNSTEIN:

I would say the special master

5

in the Court of Federal Claims, and that issue is open on

6

remand - -

7

QUESTION:

Yes.

8

QUESTION:

But Mr. Gornstein I think has raised

9

a point which he'd like guidance on in this, because

10

suppose that this child has the seizure within 3 days

11

after the DPT vaccine is administered, and suppose that

12

really is the first seizure, and the purpose of this

13

statute is so you don't have to go into a long thing about

14

causation, you don't have to go into a long thing about

15

whether there was some other, mysterious thing that caused

16

it.

17

Well, you could, on your interpretation, have to

18

go into that long thing, because if mysterious disease X

19

that nobody knows about in fact had caused something,

20

arguably, prior to the administration of the vaccine, like

21

a head-twisting, or something, then it would be open to

22

the Government to say, oh, you see, that was really the

23

first symptom, in which case by the back door you'd bring

24

in all these other mysterious, idiopathic or whatever,

25

causes.
42
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

I think -- I'm not positive, but I think that's

2

the kind of thing that was bothering him, and I think that

3

that's the sort of thing he'd like an interpretation

4

about, so what would we say about that?

5
6

7
8

MR. GORNSTEIN:

I'm not sure I follow the

hypothetical.
QUESTION:

Well, I mean, there's a mysterious

idiopathic cause, some weird thing, and the Government
wants to say, this weird thing is the cause.

10

MR. GORNSTEIN:

11

QUESTION:

Okay.

I --

Now, they're forbidden by the statute

12

to bring that up, but they might say, wait a minute, there

13

was a first symptom.

14

twisting or something --

15

MR. GORNSTEIN:

16

QUESTION:

17

MR. GORNSTEIN:

18

medical evidence that - -

1
20
21

QUESTION:

The first symptom was a neckÂ­

Well, I think --

-- even before.
Well, I think there has to be

Yes, there is.

There's a doctor who

comes in and - MR. GORNSTEIN:

-- to say that that is a

22

manifestation of encephalopathy, and if that's true, then

23

the child has not demonstrated the prima facie case, and

24

then you turn to the question of significant aggravation,

25

and you look to see whether the seizure is a manifestation
43
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)28 -2260
(800) FOR DEPO

1

of something that, a marked change in the condition *for

2

the worse.

3

QUESTION:

You could bring that in even with the

4

weird, mysterious, idiopathic mystery disease?

5

that's what's worrying him, the weird, idiopathic mystery

6

disease which had its first symptom, according to Dr. X,

7

before the vaccine was administered.

8

MR. GORNSTEIN:

You see,

You could, but I'm not sure I

see what the problem with that is, when the statute, the
10

terms of the statute say that the claimant has to show

11

that the first symptom or manifestation of encephalopathy

12

occurred after a vaccine administration.

13

And if there is a preexisting manifestation of

14

encephalopathy, and there is medical evidence to that

15

effect, it's just that we don't know what caused the

16

encephalopathy, then there's no presumption, because the

17

natural -- the natural implication of the evidence is that

18

the child already had something, and then the statute says

1

you look to whether there's significant aggravation.

20

QUESTION:

May I --

21

QUESTION:

Mr. Gornstein, assume -- I'm sorry.

22

QUESTION:

Just-- I want to follow up one point

23

on the aggravation.

24

3 days after -- within 3 days after an aggravation, the

25

child has the first seizure the child has ever had, and at

Supposing that it is true that if

44
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)28 -2260
(800) FOR DEPO

1

that point in time, that would be one symptom of a serious

2

aggravation.

3

Now, it may turn out, over -- if you look at it

4

a year later that there never was a serious aggravation.

5

This would have happened anyway.

6

looking at it as of the period 48 hours after the

7

vaccination, the table condition is satisfied if it is a

8

symptom of something that she may, in fact, not have?

9

MR. GORNSTEIN:

But is it not true that

I think that what the statute

10

says is it has to be a manifestation of a significant

11

aggravation, which means --

12

QUESTION:

13

MR. GORNSTEIN:

14

No, it has to be a symptom.

aggravation.

15

QUESTION:

16

MR. GORNSTEIN:

17
18

A manifestation of a significant

Right.
And the -- but the significant

aggravation is defined -QUESTION:

It's a symptom or a -- a first

19

symptom or manifestation, or of the significant

20

aggravation.

21

other words, the statute could be satisfied by someone

22

who's perfectly healthy, if they had the wrong symptom.

23

It seems to me that -- it seems to me, in

MR. GORNSTEIN:

If it was a -- if someone could

24

say, testify, based on that manifestation, that that was a

25

manifestation of a marked deterioration in the child's
45
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

condition, because significant aggravation is defined on

2

page 6 of our brief, 300aa(33)(4), the term significant

3

aggravation means any change for the worse in a

4

preexisting condition which results in markedly greater

5

disability, pain, or illness, accompanied by substantial

6

deterioration of health.

7

So you have to be able to say that that seizure

8

was a manifestation of that.

That is, that it was a

9

manifestation of a change for the worse in a preexisting

10

condition which results in markedly greater disability,

11

pain, or illness, and the special master carefully

12

examined that and found that it was not.

13

Seizures can be entirely benign.

They can be

14

something that is a manifestation of significant

15

aggravation.

16

between benign and significant aggravation.

17

They can be a manifestation of something in

QUESTION:

It seems to me if they're a symptom,

18

that's all the statute requires, and that's what you're

19

opponent argues here in his alternative theory.

20

MR. GORNSTEIN:

21

QUESTION:

22

MR. GORNSTEIN:

On significant aggravation?

Yes.
Well, I think it has to - - I

23

would repeat my argument that it's not enough for it to be

24

a symptom.

25

significant aggravation.

It has to be a manifestation or a symptom of a

46
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

QUESTION:

1

But manifestation is in the

2

dysjunctive, compared to symptom, symptom or

3

manifestation.
MR. GORNSTEIN:

4
5

special master found it was neither in this case.

6

QUESTION:

7

MR. GORNSTEIN:

8

QUESTION:

9

That's right, and it was -- the

My I try out two alternatives -Sure.

-- to see if I understand your

position.

10

Assume Justice Breyer's hypothetical.

11

seizure occurs whatever it was, a day after the

12

vaccination.

13

head-twisting, neck-twisting of some sort.

14

The first

Prior to the vaccination there has been

The medical evidence, the Government presents

15

medical evidence in the first case, the first

16

hypothetical, by a doctor who says, in my judgment there

17

probably was a relationship between the seizure and the

18

preexisting neck-twisting.

19

syndrome, but I think that's what we're ultimately going

20

to find, so for that reason I posit a cause of the seizure

21

which is not the vaccination.

22

1.

23

That is not a standard

That's hypothetical number

Hypothetical number 2, the doctor says, there is

24

in fact a recognized syndrome or condition in which

25

seizures and neck-twisting go together.
47
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

You get neck-

1

twisting, you know you're going to get a seizure or

2

there's going to be a high probability of a seizure later

3

on.

4

understood as kind of a standard diagnostic category, and

5

we call that category disease X.

6

do with vaccinations.

7

anyway because you had the neck-twisting.

8

9

This conjunction of symptoms is readily observed and

Disease X has nothing to

You would have gotten the seizure

As I understand your position, in the first
case, the claimant would have made out at least a case for

10

the presumption.

11

hypothesis of an idiopathic cause which nobody but the

12

doctor testifying knows about.

13

It would not have been affected by this

In the second case, the presumption would not

14

apply, because, in fact, no reasonable finder of fact

15

would conclude, if they accepted the doctor as telling the

16

truth and as a competent medical expert, no reasonable

17

finder of fact would -- in fact would conclude that

18

this -- that the seizure was, in fact, a first

19

manifestation of an aggravation.

20

Is that your position?

21

MR. GORNSTEIN:

22

agree with that description.

23

QUESTION:

24

MR. GORNSTEIN:

25

Justice Souter, I'm not sure I

Okay.

Well then, correct me then.
I think that as long -- in the

first case, even if you don't know what caused it, if you
48
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

can say, this is a manifestation of encephalopathy, and

2

that is the table condition that the claimant is seeking

3

compensation for, and the person doesn't know exactly --

4

QUESTION:

Well, you mean, even if you don't

5

know what causes encephalopathy - -

6

MR. GORNSTEIN:

7

QUESTION:

8

9
10
11
12

That's right.

-- but there is always seizures that

go with encephalopathy - MR. GORNSTEIN:
QUESTION:

But that --

- - and you have evidence of

preexisting encephalopathy.
MR. GORNSTEIN:

Okay.

But that's the key, is

13

encephalopathy, because that's what the table says you can

14

recover for, either the onset of encephalopathy, or a

15

significant aggravation of encephalopathy.

16

That's the key condition, and so when you go

17

back and say, what happened before table time, the

18

question you're asking under the first part of our

19

analysis is, was there a symptom or manifestation of

20

encephalopathy, not of head-jerking, or anything else.

21

could be - - you get nowhere with head-jerking.

22

It

On the second part of our analysis, if you could

23

show that head-jerking is some sort of defined condition

24

that causes, ultimately, encephalopathy, then you would

25

win as a -- on a factor unrelated, even if the first
49
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

1

symptom or manifestation of that condition occurred after

2

the administration of the vaccine, and that's the

3

difference between our two theories.

4

QUESTION:

What about the residual seizure

5

disorder point?

6

that that was not established.

7

I thought it was decided by the master

MR. GORNSTEIN:

That's right.

The special

8

master found that there was not a residual seizure

9

disorder because the - - one of the requirements is that

10

the effects last for a period of more than 6 months, and

11

the special master found that that was not so with respect

12

to residual seizure disorder.

13
14
15
16

CHIEF JUSTICE REHNQUIST:
Mr. Gornstein.

Thank you,

The case is submitted.

(Whereupon, at 11:05 a.m., the case in the
above-entitled matter was submitted.)

17
18
19
20
21
22

23
24
25
50
ALDERSON REPORTING COMPANY, INC.
1111 FOURTEENTH STREET, N.W.
SUITE 400
WASHINGTON, D.C. 20005
(202)289-2260
(800) FOR DEPO

CERTIFICATION

Alderson Reporting Company, Inc., hereby certifies that the
attached pages represents an accurate transcription of electronic
sound recording of the oral argument before the Supreme Court of
The United States in the Matter of:
DONNA E. SHALALA. SECRETARY OF HEALTH & HUMAN SERVICES. Petitioner
v. MARGARET WHITECOTTON. ET AL.
CASE NO.: 94-372
and that these attached pages constitutes the original transcript of
the proceedings for the records of the court.

BY
(REPORTER)

